<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two murine models of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> were employed to challenge an hypothesized mechanism by which <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (APLA) might promote <z:mp ids='MP_0005048'>thrombosis</z:mp>: altering prostacyclin (<z:chebi fb="0" ids="15552">PGI2</z:chebi>) and <z:chebi fb="0" ids="26995">thromboxane</z:chebi> (TX) production </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="15552">PGI2</z:chebi> levels in mouse blood and the ex vivo release of <z:chebi fb="0" ids="15552">PGI2</z:chebi> and TX from mouse kidney were measured </plain></SENT>
<SENT sid="2" pm="."><plain>Since APLA have been reported to alter synthesis or activation of several molecules mediating fibrinolysis, murine plasma levels of the fibrin degradation product, D-dimer were also determined </plain></SENT>
<SENT sid="3" pm="."><plain>Two murine strains, one prone to spontaneous "<z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>-like" illness (MRL-lpr) and related strain (MRL-(+2)), were compared </plain></SENT>
<SENT sid="4" pm="."><plain>The assays confirm that MRL-lpr mice have increased anticardiolipin antibody (ACA) and two-fold increased release of TX from renal tissues compared to MRL-(+2) mice </plain></SENT>
<SENT sid="5" pm="."><plain>However, these mice have low levels of plasma D-dimer </plain></SENT>
<SENT sid="6" pm="."><plain>NIH Swiss mice injected with IgG (containing APLA) from <z:mp ids='MP_0005048'>thrombosis</z:mp>-prone <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> patients had high blood ACA titers and D-dimer levels, but both ACA and D-dimer were low or non-detectable in Swiss mice injected with saline or <z:mpath ids='MPATH_458'>normal</z:mpath> IgG </plain></SENT>
<SENT sid="7" pm="."><plain>Unlike mice with spontaneous <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>-like illness, healthy mice injected with APLA did not differ from controls with respect to plasma or tissue <z:chebi fb="0" ids="15552">PGI2</z:chebi> or TX levels </plain></SENT>
<SENT sid="8" pm="."><plain>The two murine models of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> differ, because an altered <z:chebi fb="0" ids="15552">PGI2</z:chebi>-TX ratio is a finding in the <z:hpo ids='HP_0011010'>chronic</z:hpo> murine <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> strain MRL-lpr, but is not seen when APLA are injected into <z:mpath ids='MPATH_458'>normal</z:mpath> mice </plain></SENT>
<SENT sid="9" pm="."><plain>It is unlikely that APLA alone has a direct effect on cellular production of <z:chebi fb="0" ids="23899">eicosanoids</z:chebi> in vivo </plain></SENT>
</text></document>